Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000469
Filing Date
2025-01-24
Accepted
2025-01-24 16:38:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2856
  Complete submission text file 0001959173-25-000469.txt   4329
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Subject) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-29889 | Film No.: 25554670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Masuda Esteban (Reporting) CIK: 0001686849 (see all company filings)

Type: 144